RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY

Phase 3

• Conditions: Sigmoidal Tumour
• Interventions: Drug: MORPHINE; Drug: L-BUPIVACAINE ; MORPHINE

• Registration Number: NCT01825993
• Lead Sponsor: Corporacion Parc Tauli

Brief Summary

The investigators would study the control of postoperative pain with peridural catheter, morphine PCA ev or Transabdominal block.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-03-29
• Status Verified: 2013-04
• Study Start: 2013-04
• Study First Submitted QC: 2013-04-05
• Last Update Submitted: 2013-04-05
• Study First Posted: 2013-04-08
• Last Update Posted: 2013-04-08
• Primary Completion: 2015-04
• Study Completion: 2015-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 225

Inclusion Criteria

• Age more than 18
• Laparoscopic sigmoidectomy
• Informed consent firmed

Exclusion Criteria

• ASA IV
• Urgent surgery
• Sigmoid tumour stage IV
• Cronic pain treatment
• No informed consent firmed
• Paliative surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PCA endovenous	MORPHINE	1mg/10 min Morphine
PERIDURAL CATHETER	L-BUPIVACAINE ; MORPHINE	Peridural L-bupivacaine 0.25%
TANSABDOMINAL BLOCK (TAP)	L-BUPIVACAINE ; MORPHINE	L-BUPIVACAINE im

Primary Outcome Measures

Name	Time	Method
EVA (POSTOPERATIVE PAIN)	72 H POSTOPERATIVE	The investigators asked the patient the postoperative pain during teh first 72 hours by EVA scale.

Secondary Outcome Measures

Name	Time	Method
ADVERSE EFFECTS	five days	the investigators look for adverse effects

Trial Locations

Locations (1)

Corporacion Parc Tauli; 🇪🇸 Sabadell, Sabadell-barcelona, Spain